Novocure Unveils Encouraging Trial Outcomes for TTFields Treatment in Pancreatic Cancer
Novocure recently disclosed favorable initial results from its Phase 3 investigation of Tumor Treating Fields (TTFields) therapy for pancreatic cancer. The PANOVA-3 study revealed a notable enhancement in overall survival for patients with non-resectable, locally advanced pancreatic adenocarcinoma treated with […]
Novocure Unveils Encouraging Trial Outcomes for TTFields Treatment in Pancreatic Cancer Read More »